Barrington Research Reiterates Outperform on Merit Medical Systems, Maintains $95 Price Target
Portfolio Pulse from richadhand@benzinga.com
Barrington Research analyst Michael Petusky has reiterated an 'Outperform' rating on Merit Medical Systems (NASDAQ:MMSI) and maintained a $95 price target.
July 06, 2023 | 1:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems (NASDAQ:MMSI) has been reiterated with an 'Outperform' rating by Barrington Research, with a maintained price target of $95.
The reiteration of an 'Outperform' rating by a research firm typically indicates a positive outlook for the company's stock. The maintained price target of $95 also suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100